Primary thyroid marginal zone B-cell lymphoma MALT-type in a patient with rheumatoid arthritis


Serefhanoglu S., Tapan U., Ertenli I., KALYONCU U., ÜNER A.

MEDICAL ONCOLOGY, vol.27, no.3, pp.826-832, 2010 (SCI-Expanded) identifier

  • Publication Type: Article / Article
  • Volume: 27 Issue: 3
  • Publication Date: 2010
  • Doi Number: 10.1007/s12032-009-9293-x
  • Journal Name: MEDICAL ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.826-832
  • Keywords: Thyroid, MALT lymphoma, Rheumatoid arthritis, SJOGRENS-SYNDROME, THERAPY, RITUXIMAB, DIAGNOSIS, DISEASE, RISK
  • Hacettepe University Affiliated: Yes

Abstract

Autoimmune diseases are defined as specific, adapted immune reactions against self antigens. Immune mechanism deficiency is a causal factor for B-cell lymphoma in primary Sjogren's syndrome and autoimmune thyroid disease. Thyroid mucosa-associated lymphoid tissue (MALT) lymphoma is a 67-fold and parotid lymphoma is a 44-fold increased risk in Sjogren's syndrome and thyroiditis. MALT lymphoma was not reported in rheumatoid arthritis. We herein report the case of a 56-year-old woman with maltoma of thyroid in rheumatoid arthritis patient.